Earnings summary
4D Molecular Therapeutics, Inc. Q4 2025 results
Snapshot
4D Molecular Therapeutics, Inc. reported $85M of revenue in Q4 2025, up 8508900.0% year over year, with diluted EPS of $0.43 and an operating margin of 17.3%.
- Revenue
- $85M
- YoY growth
- +8508900.0%
- Diluted EPS
- $0.43
- Operating margin
- 17.3%
$85M
Revenue
+8508900.0%
YoY growth
$0.43
Diluted EPS
17.3%
Operating margin